BioCentury
ARTICLE | Clinical News

FDA regulatory update

February 22, 1994 8:00 AM UTC

The agreement also limits the Russian ministry's review period to 90 days. The registration procedure - which is the prerequisite for product marketing in Russia - previously had no time limit. ...